Multicenter evaluation of the Panbio COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection.
Detection Principle
ImmunoAssay-Antigen
Target
not specified
Testing Method Category
Other
Testing Method
kit
Testing Method - Additional Info
Panbio COVID-19 Ag Rapid Test Device (PanbioRT) (Abbott)
Reported Performance
sensitivity: 90.5% (overall), 99.5% (in patients with PCR Ct<25), 91.8% (< 5 dpo); specificity: 98.8%; agreement with PCR: 95.7%; NPV: 94.6%; PPV: 97.8%
Sample Size
958 patients
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements